Trillo Aliaga, P.; Trapani, D.; Sandoval, J.L.; Crimini, E.; Antonarelli, G.; Vivanet, G.; Morganti, S.; Corti, C.; Tarantino, P.; Friedlaender, A.;
et al. Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers 2021, 13, 5829.
https://doi.org/10.3390/cancers13225829
AMA Style
Trillo Aliaga P, Trapani D, Sandoval JL, Crimini E, Antonarelli G, Vivanet G, Morganti S, Corti C, Tarantino P, Friedlaender A,
et al. Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers. 2021; 13(22):5829.
https://doi.org/10.3390/cancers13225829
Chicago/Turabian Style
Trillo Aliaga, Pamela, Dario Trapani, José Luis Sandoval, Edoardo Crimini, Gabriele Antonarelli, Grazia Vivanet, Stefania Morganti, Chiara Corti, Paolo Tarantino, Alex Friedlaender,
and et al. 2021. "Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials" Cancers 13, no. 22: 5829.
https://doi.org/10.3390/cancers13225829
APA Style
Trillo Aliaga, P., Trapani, D., Sandoval, J. L., Crimini, E., Antonarelli, G., Vivanet, G., Morganti, S., Corti, C., Tarantino, P., Friedlaender, A., Belli, C., Minchella, I., Locatelli, M., Esposito, A., Criscitiello, C., & Curigliano, G.
(2021). Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers, 13(22), 5829.
https://doi.org/10.3390/cancers13225829